Groundbreaking Nikon Instruments Inverted Research

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Groundbreaking Nikon Instruments Inverted Research Microscope Among New Releases at Neuroscience 2016

New ECLIPSE Ti2 Inverted Research Microscope doubles field of view, revolutionizes how researchers capture data with microscope

MELVILLE, N.Y., Nov. 14, 2016 (GLOBE NEWSWIRE) --   Nikon Instruments Inc ., innovator of advanced optical instruments, is debuting the all-new ECLIPSE Ti2 Inverted Research Microscope at the Society for Neuroscience’s annual Neuroscience 2016 meeting in San Diego this week. This microscope revolutionizes how researchers capture data, delivering an unprecedented 25mm field of view that allows for accelerated research, as well as improved stability and usability powered by an intelligent microscope operation guide. Nikon will also showcase several other state-of-the art multiphoton, confocal, super-resolution and optogenetics systems configured for neurobiology applications at Booth #2513.

“Nikon is constantly pushing the boundaries to expand imaging capabilities for scientists to address critical research questions, and every year we look forward to sharing our latest innovations with our SFN community,” said Steve Ross, Ph.D., General Manager, Products and Marketing, Nikon Instruments Inc. “This is a truly exciting year, starting with the ECLIPSE Ti2 inverted research microscope series which offers a groundbreaking large field of view to revolutionize and accelerate research and the collection of state-of-the art systems for neurobiology we’re unveiling in San Diego.”

The new ECLIPSE Ti2 is the successor to the iconic ECLIPSE Ti Inverted Research Microscope, and, along with the unprecedented FOV, features integrated fly-eye lens technology to provide uniform edge-to-edge illumination of the large FOV while redesigned large fluorescence filter cubes further ensure flat field imaging. Furthermore, the Ti2 incorporates a fourth generation Perfect Focus System (PFS) which once again improves upon the industry leading auto-focusing mechanism and combined with a newly redesigned z-drive, provide an ultra-stable imaging experience. The microscope also offers intelligent functions to guide users through imaging workflows by gathering data from internal sensors – eliminating the possibility of user errors. Large FOV imaging capability of the Ti2 as well as new accessories such as the auto correction collar (ACC) will be on display.  

In addition to the new inverted research microscope, Nikon will also be displaying a collection other state-of-the art super-resolution, multiphoton, and confocal systems.

Even more from Nikon Instruments

  • Super-resolution systems N-SIM and N-STORM with Ti2.   The new Ti2 inverted research microscope provides an ultra-stable, high precision focusing drive for nanoscale imaging.  The Ti2’s new ACC feature allows users to easily gain maximum performance from the super-resolution objectives. N-SIM doubles the resolution of conventional light microscopy and is well-suited for multi-channel, live-cell imaging. New N-SIM innovations include improved image reconstruction workflows. N-STORM provides 10-fold improvement in resolution in 3-dimensions and is compatible with Z-stacking.  
  • FN1:  An Electrophysiology Stand for Optogenetics . Researchers can control neural activity with a digital micro-mirror device which provides simultaneous, multi-ROI photostimulation capability. The ultra-slim FN1 microscope body with 360° access around the objective allows easy manipulator positioning for recording neural activity.  
  • A1r-MP Multiphoton Confocal System . High-speed resonant scanner and dual IR laser inputs enable fast, 2-color multiphoton imaging.  
  • NEW Plan Apo 10xC Glyc objective for clearing applications.   Compatible with both upright and inverted microscopes, this new objective is designed for deep tissue imaging of cleared samples.  The objective features long working distance and high N.A. and is corrected for chromatic aberration across a broad wavelength range (405-1064nm). Nikon’s proprietary anti-reflective Nano Crystal coating provides high transmission from UV to near IR.  The lens accommodates a wide range of refractive indices and is compatible with a variety of clearing techniques.  
  • Large-Format A1rMP for Intravital Imaging . This open architecture accommodates large specimens and stereotactic devices and allows for flexible configuration for custom intra-vital imaging and optogenetics.  
  • Flexible Illuminators and Laser Combiner for Multimodal Imaging.
    • LAPPs:  Modular illuminators to flexibly combine multi-angle TIRF, FRAP, and Optogenetics with SR, Confocal and MP.
    • LUNV:  Permanently aligned, solid-state laser combiner.  Researchers can choose from eight different lasers and five output fibers for true multimodal imaging.

Neuroscience 2016 attendees are invited to experience all of the above systems and products at Nikon’s booth #2513.

ABOUT NIKON INSTRUMENTS INC . Nikon Instruments Inc. is a world leader in the development and manufacture of optical and digital imaging technology for biomedical applications. Now in its 99 th year, Nikon provides complete optical systems that offer optimal versatility, performance and productivity. Cutting-edge instruments include microscopes, digital imaging products and software. Nikon Instruments is one of the microscopy and digital imaging arms of Nikon Inc., the world leader in digital imaging, precision optics and photo imaging technology. For more information, visit www.nikoninstruments.com . Product-related inquiries may be directed to Nikon Instruments at 800-52-NIKON.

Trisha Bruynell Peppercomm 212.931.6129 tbruynell@peppercomm.com Nicole Newby Peppercomm 212.931.6164 nnewby@peppercomm.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Dr. Obeng Joins WellcomeMD with Special Offer for Patients

Updated Category News Views 47

New Beginnings in Concierge Medicine In late October, WellcomeMD opened its doors to Dr. Paa-Kofi Obeng—an arrival greeted with considerable anticipation in Richmond's medical scene. This isn't just any run-of-the-mill staff addition; Dr. Obeng brings with him over a decade of experience from places like the Veterans Administration Medical Center. He's armed with a...

Continue Reading
Ross Pools Joins Forces with Florida Panthers in 2026

Updated Category News Views 56

An Unlikely Team-Up: Pools and Hockey Well, here's one for the books: a South Florida pool company hitching its wagon to an NHL team. Ross Pools, the folks who’ve been carving out backyard oases in the sizzling Florida sun for over two decades, are now officially aligned with the Florida Panthers. Yeah, the same Panthers that snatched the Stanley Cup not once but twice...

Continue Reading
Halfday Iced Tea Shakes Up U.S. Retail Scene

Updated Category News Views 142

Halfday's Meteoric Rise in the U.S. Market Sometimes, you pick up a can of iced tea, and it just changes the game. That’s exactly what Halfday is doing, stepping on the accelerator and leaving traditional iced tea brands in the dust. With their latest announcement, they've snagged the title of the fastest-growing modern tea brand in U.S. multi-outlet retail. It's the...

Continue Reading
Webull Faces FINRA Fine and Legal Battle Ahead

Updated Category News Views 187

Webull's Compliance Headache Webull’s been knocked around again. This time, the Financial Industry Regulatory Authority (FINRA) slapped it with a hefty $4.2 million fine. Talk about a hit to the wallet! It all boils down to them failing to roll out some basic anti-money laundering (AML) and other crucial compliance programs. This is no small oversight, and it's got...

Continue Reading
Clinch Scores Big with Two Prestigious Industry Honors

Updated Category News Views 101

Clinch's Dual Triumph in Advertising Innovation No one throws a ticker symbol over their cereal for recognizing brilliance, but when an outfit like Clinch gets double applause at the big dance, even we old-timers have to tip our hats. On November 16, 2026, the advertising world saw some fireworks. Clinch took home not one but two hefty awards—the kind that say you've...

Continue Reading
FDA Changes Shake Up Medtech Inspections Landscape

Updated Category News Views 124

Inspecting the Changing FDA Landscape If you’ve been treating FDA inspections like a ride down memory lane, it's time for a wake-up call. What F. David Rothkopf plans to tell the medical device teams at the MEDevice Silicon Valley event is simple: the game has changed. The FDA’s Quality Management System Regulation (QMSR) that kicked in on February 2, 2026, isn’t...

Continue Reading
Vipshop Prepares for Q3 Financial Results Release

Updated Category News Views 93

Countdown to Vipshop's Third Quarter Results November 24th might just be another day on the calendar for some, but for those of us keeping tabs on the markets, it's a make-or-break moment for Vipshop Holdings Limited. The off-price retail titan from China, trailing under the ticker NYSE:VIPS, is gearing up to swing the doors wide open on its third-quarter financial...

Continue Reading
Luxury Villa Cashback Offers Entice Travelers in November

Updated Category News Views 134

A November Bonanza for Villa Bookings Who doesn't love having a few extra bucks in their pocket, especially when they come with the allure of luxury travel? Villas of Distinction is rolling out what they call a 'November Cashback Offer,' and for those with the wallet—and wanderlust—to match, it could be a tempting proposition. Hanging the bait of up to $2,000 cashback...

Continue Reading
Lennar Faces Securities Fraud Lawsuit: Investor Insights

Updated Category News Views 150

Investors in Lennar: Navigating the Legal Storm Hold onto your hats, folks. Lennar Corporation (NYSE: LEN) is up against it with a brand-spanking-new securities fraud lawsuit helmed by Schall, Brown & Schwartz LLP (SBS). This isn't just a couple of investors grumbling over cocktails; it’s a full-blown class action that’s waving the legal banner under the Securities...

Continue Reading
Tenax Therapeutics Facing Class Action: DEC 28 Deadline

Updated Category News Views 92

Legal Storm Over Tenax Therapeutics Just what the doctor didn't order—legal headaches for Tenax Therapeutics, Inc. (NASDAQ:TENX). Yup, folks, buckle up because we're diving into another class action mudslinging match that’s setting the markets wagging. Berger Montague's law trebuchet is aimed squarely at Tenax and every investor should know the target’s outline....

Continue Reading

Top 5 Most Recently Viewed Articles

Navigating the Growth of the Digital Signage Market Today

Updated Category News Views 84

The digital signage market was transforming fast, with projections showing a jump from USD 20.1 billion in 2024 to around USD 27.3 billion by 2029—talk about a solid compound annual growth rate of 6.3%. Traders were buzzing over the factors driving this upward trend: high-res displays and expanding infrastructure in emerging markets had everyone seeing green. Market...

Continue Reading
Exploring the Potential of Healthcare Stocks Amid Market Growth

Updated Category News Views 189

The stock market is navigating through exciting times, with the S&P 500 recently eclipsing the significant milestone of 5,700 points. This robust performance is fueled by a dynamic shift as investors increasingly look towards emerging sectors, particularly healthcare, which is gaining momentum this earnings season. This year, we've seen an impressive trend, with over 40...

Continue Reading
Recognizing Excellence: Nominate for the Paralegal of the Year Award

Updated Category News Views 217

Nominations Now Open for the 2025 AAJ Paralegal of the Year Award The American Association for Justice (AAJ) proudly announces that nominations for the 2025 Paralegal of the Year Award are now open. This award, sponsored by Advocate Capital, Inc., is a wonderful opportunity to acknowledge and applaud the significant contributions of paralegals within our civil justice...

Continue Reading
Mavsign and RouteOne Revolutionize Automotive Deal Processes

Updated Category News Views 174

Mavsign and RouteOne Transforming Automotive Transactions Mavsign, renowned for its expertise in remote document signings and compliance solutions, has announced an exciting partnership with RouteOne, a leader in automotive financing solutions. This collaboration aims to enhance the efficiency and security of automotive transactions by integrating both companies'...

Continue Reading
Revance Stockholders Encouraged to Support Crown's Tender Offer

Updated Category News Views 122

Crown's Tender Offer for Revance Stock: Key Information Revance Therapeutics, Inc. (NASDAQ: RVNC) stockholders are being urged to support Crown Laboratories, Inc. by tendering their shares before the upcoming deadline. This is an important moment as Crown's tender offer presents the only current proposal post Teoxane's withdrawal. Details of the Crown Offer Crown has made...

Continue Reading